-
Trendspotting: Hybrid and Decentralized Clinical Trials, Patient-Centricity, and Increased Remote Patient Monitoring in 2023
Clinical Research News | We spoke with clinical research leaders about their expectations for the coming year. They predicted that hybrid and decentralized trials (DCTs) would eventually become the industry standard, brick-and-mortar sites will employ flexibility to increase patient retention, and companies will rely heavily on remote patient monitoring and wearable devices to stretch their budgets and combat the looming economic downturn.
Jan 5, 2023
-
AbbVie’s Christopher Boone on Disrupting the Clinical Research Enterprise With Real-World Data and Evidence
Clinical Research News | In recent years, pharmaceutical and life science companies have leveraged real-world evidence (RWE) to maximize patient recruitment and formulate clinical trial criteria. In the latest episode of the Scope of Things podcast, Christopher Boone, Ph.D., vice president and global head of health economics and outcomes research at AbbVie, talks about the disruptive nature of RWE and its impact on clinical trial design.
Jan 3, 2023
-
Top Stories of 2022: Decentralized Trials, Data Science for Trials
Clinical Research News | Decentralized trials have been on everyone’s lips this past year. The first real data coming in on the success and value of new trial formats has also prompted other questions around standardizing vocabulary, prioritizing the incorporation of new pharmacists, and more. In addition, new data science technologies including machine learning and “tokenization” aim to shape clinical research.
Dec 29, 2022
